BristolMyers Squibb Company (BMY, rated BUY)
July 3, 2008
BMY has paid a dividend of $0.31 per share.
| Analysts’ Recommendation: |
Buy |
| 30 Days Ago: | Buy |
|
|
|
| Analysts’ Target: | $30 |
BristolMyers Squibb Company (BMY, rated BUY)
Subscribe To Site:
Comments
Comments »
-
Recent Posts
- Renewed Infrastructure Growth in Environmentalists’ Best Interest
- Geithner, Summers Represent Change at Treasury
- Existing Home Sales Clunk Along Bottom
- Shelf Filings Are Increasing, But Don’t Get Excited
- More on Hindsight Bias
- Obama’s Real Economic Team
- Forex Interplay: Euro vs. Dollar As Risk Appetite Returns
- U.S. Public Pension Plans Able to Recover from Market Slump
- Profiting From Risk Aversion
- Wall Street Journal: Homebuilders Want $250 Billion Stimulus
-
Latest S.E.C. Filings- 6-K - Nevoro Inc. (0001432768) (Filer)
- 6-K - Nevoro Inc. (0001432768) (Filer)
- 6-K - Nevoro Inc. (0001432768) (Filer)
- 6-K - Nevoro Inc. (0001432768) (Filer)
- 6-K - Nevoro Inc. (0001432768) (Filer)
- 6-K - Nevoro Inc. (0001432768) (Filer)
- DEF 14A - Sally Beauty Holdings, Inc. (0001368458) (Filer)
- 20-F - NOVOGEN LTD (0001075880) (Filer)
- N-CSRS - TORREY US STRATEGY PARTNERS LLC (0001170035) (Filer)
- N-CSRS - TORREY INTERNATIONAL STRATEGY PARTNERS LLC (0001170123) (Filer)
Message Boards
The Original Investors Paradise Forums
Translate Investors Paradise
 |  |  |  |  |  |  |  |  |  |  |  |  |
No comments yet.